The authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among patients coinfected with HIV.
Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range.
For future studies focusing on quality of care from the background of the Chronic Care Model, the PACIC short form is appropriate.
Use of health information technology in acute care settings is associated with modestly lower rates of adverse patient safety outcomes for inpatient and surgical care.
Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.
Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Accountable care organizations (ACOs) deliver a diverse array of home-based services, but many of the services are not reimbursed. ACOs may not expand these programs without strong evidence of cost savings.
Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.
In the 6 years following inpatient electronic health record (EHR) implementation, an average of 2.5 significant EHR changes per day were made for maintenance and improvement.
A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.
Moderate underreporting biases were found when patient responses to an interactive voice response system were compared with medical records in the STAR*D clinical trial.
Complex care is cross-sector and person-centered, and it could bend America’s healthcare cost curve. The Blueprint for Complex Care gives this new field a national framework.